Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report

Table 2 Recommended follow-up for metastatic seminoma and non-seminoma germ cell tumors

	Year 1	Year 2	Year 3–5
Physical examination	Q3 months	Q3 months	Q6 months
Laboratory investigations including tumor markers (AFP, b-HCG, LDH)	Q3 months	Q3 months	Q6 months
CXR	Q3 months	Q3 months	Q6 months
CT abdomen/pelvis	Q6 months	Q6 months	Q12 months
CT chest	Q12 months	Q12 months	Q12 months

AFP alpha-fetoprotein, b-HCG beta- human chorionic gonadotrophin, CT computed tomography, CXR chest X-ray, LDH lactate dehydrogenase, Q every (adopted from the European Association of Urology [5])

ISSN: 1752-1947